2026

Kong, C. Y. et al. (2026) Interrogating local recurrence biology in rectal cancer employing bulk gene Expression profiling. Diseases of the Colon and Rectum, (Accepted for Publication)

Hillson, L. V. S. et al. (2026) Immune and stromal tumour biology associated with neoadjuvant radiotherapy response in locally advanced rectal cancer. British Journal of Cancer, (doi: 10.1038/s41416-026-03575-y) (Early Online Publication)

Hillson, L. V.S. et al. (2026) Differential immunologic effects of short-course and long-course radiotherapy in locally advanced rectal cancer. Clinical Cancer Research, (doi: 10.1158/1078-0432.CCR-25-2733) (Early Online Publication)

2025

Berardi, D. et al. (2025) Senescence cell induction methods display diverse metabolic reprogramming and reveal an underpinning serine/taurine reductive metabolic phenotype. Aging Cell, 24(8), e70127. (doi: 10.1111/acel.70127) (PMID:40530891)

Woraharn, W. et al. (2025) Investigation of three alternative histopathological scoring methods at the invasive tumour front in colorectal cancer. Journal of Pathology: Clinical Research, 11(3), e70031. (doi: 10.1002/2056-4538.70031) (PMID:40374531) (PMCID:PMC12081161)

Craig, Rachel ORCID: https://orcid.org/0000-0001-8929-7055, McIntosh, Kathryn, Ho Ho, Ka, McCulloch, Ashley ORCID: https://orcid.org/0000-0003-4151-1563, Riley, Christopher, Lawson, Christopher, Mackay, Simon P., Paul, Andrew, Coats, Paul and Plevin, Robin (2025) IL-1β stimulates a novel axis within the NFκB pathway in endothelial cells regulated by IKKα and TAK-1. Biochemical Pharmacology, 232, 116736. (doi: 10.1016/j.bcp.2024.116736) (PMID:39710275)

2024

Hillson, Lily Victoria Sarah, McCulloch, Ashley Kathryn ORCID: https://orcid.org/0000-0003-4151-1563, Edwards, Joanne ORCID: https://orcid.org/0000-0002-7192-6906, Dunne, Philip David, O'Cathail, Sean Michael ORCID: https://orcid.org/0000-0001-5574-9199 and Roxburgh, Campbell Stuart ORCID: https://orcid.org/0000-0002-2649-6695 (2024) Radiation-induced changes in gene expression in rectal cancer specimens. Clinical and Translational Oncology, 26(6), pp. 1419-1428. (doi: 10.1007/s12094-023-03361-9) (PMID:38243085) (PMCID:PMC11108951)

2023

Beach, C. et al. (2023) Improving radiotherapy in immunosuppressive microenvironments by targeting complement receptor C5aR1. Journal of Clinical Investigation, 133(23), e168277. (doi: 10.1172/JCI168277) (PMID:37824211) (PMCID:PMC10688992)

McIntosh, K. et al. (2023) IL-1β stimulates a novel, IKKα -dependent, NIK -independent activation of non-canonical NFκB signalling. Cellular Signalling, 107, 110684. (doi: 10.1016/j.cellsig.2023.110684) (PMID:37080443)

2020

McAllister, Milly J., McCall, Pamela, Dickson, Ashley ORCID: https://orcid.org/0000-0003-4151-1563, Underwood, Mark A., Andersen, Ditte, Holmes, Elizabeth, Market, Elke, Leung, Hing Y. ORCID: https://orcid.org/0000-0002-3933-3975 and Edwards, Joanne ORCID: https://orcid.org/0000-0002-7192-6906 (2020) Androgen receptor phosphorylation at serine 81 and serine 213 in castrate-resistant prostate cancer. Prostate Cancer and Prostatic Diseases, 23(4), pp. 596-606. (doi: 10.1038/s41391-020-0235-1) (PMID:32358577)

2018

Roseweir, A. K. et al. (2018) Predictive biomarkers for endocrine therapy: retrospective study in Tamoxifen and Exemestane Adjuvant Multinational (TEAM) trial. Journal of the National Cancer Institute, 110(6), pp. 616-627. (doi: 10.1093/jnci/djx255) (PMID:29917140)

Campbell, K. J. et al. (2018) MCL-1 is a prognostic indicator and drug target in breast cancer. Cell Death and Disease, 9, 19. (doi: 10.1038/s41419-017-0035-2) (PMID:29339815) (PMCID:PMC5833338)

2017

Cheng, Kelvin K.W., Dickson, Ashley ORCID: https://orcid.org/0000-0003-4151-1563, Gujam, Fadia J.A., McMillan, Donald C. ORCID: https://orcid.org/0000-0003-4260-5334 and Edwards, Joanne ORCID: https://orcid.org/0000-0002-7192-6906 (2017) The relationship between oestrogen receptor-alpha phosphorylation and the tumour microenvironment in patients with primary operable ductal breast cancer. Histopathology, 70(5), pp. 782-797. (doi: 10.1111/his.13134) (PMID:27891654)

Articles

Kong, C. Y. et al. (2026) Interrogating local recurrence biology in rectal cancer employing bulk gene Expression profiling. Diseases of the Colon and Rectum, (Accepted for Publication)

Hillson, L. V. S. et al. (2026) Immune and stromal tumour biology associated with neoadjuvant radiotherapy response in locally advanced rectal cancer. British Journal of Cancer, (doi: 10.1038/s41416-026-03575-y) (Early Online Publication)

Hillson, L. V.S. et al. (2026) Differential immunologic effects of short-course and long-course radiotherapy in locally advanced rectal cancer. Clinical Cancer Research, (doi: 10.1158/1078-0432.CCR-25-2733) (Early Online Publication)

Berardi, D. et al. (2025) Senescence cell induction methods display diverse metabolic reprogramming and reveal an underpinning serine/taurine reductive metabolic phenotype. Aging Cell, 24(8), e70127. (doi: 10.1111/acel.70127) (PMID:40530891)

Woraharn, W. et al. (2025) Investigation of three alternative histopathological scoring methods at the invasive tumour front in colorectal cancer. Journal of Pathology: Clinical Research, 11(3), e70031. (doi: 10.1002/2056-4538.70031) (PMID:40374531) (PMCID:PMC12081161)

Craig, Rachel ORCID: https://orcid.org/0000-0001-8929-7055, McIntosh, Kathryn, Ho Ho, Ka, McCulloch, Ashley ORCID: https://orcid.org/0000-0003-4151-1563, Riley, Christopher, Lawson, Christopher, Mackay, Simon P., Paul, Andrew, Coats, Paul and Plevin, Robin (2025) IL-1β stimulates a novel axis within the NFκB pathway in endothelial cells regulated by IKKα and TAK-1. Biochemical Pharmacology, 232, 116736. (doi: 10.1016/j.bcp.2024.116736) (PMID:39710275)

Hillson, Lily Victoria Sarah, McCulloch, Ashley Kathryn ORCID: https://orcid.org/0000-0003-4151-1563, Edwards, Joanne ORCID: https://orcid.org/0000-0002-7192-6906, Dunne, Philip David, O'Cathail, Sean Michael ORCID: https://orcid.org/0000-0001-5574-9199 and Roxburgh, Campbell Stuart ORCID: https://orcid.org/0000-0002-2649-6695 (2024) Radiation-induced changes in gene expression in rectal cancer specimens. Clinical and Translational Oncology, 26(6), pp. 1419-1428. (doi: 10.1007/s12094-023-03361-9) (PMID:38243085) (PMCID:PMC11108951)

Beach, C. et al. (2023) Improving radiotherapy in immunosuppressive microenvironments by targeting complement receptor C5aR1. Journal of Clinical Investigation, 133(23), e168277. (doi: 10.1172/JCI168277) (PMID:37824211) (PMCID:PMC10688992)

McIntosh, K. et al. (2023) IL-1β stimulates a novel, IKKα -dependent, NIK -independent activation of non-canonical NFκB signalling. Cellular Signalling, 107, 110684. (doi: 10.1016/j.cellsig.2023.110684) (PMID:37080443)

McAllister, Milly J., McCall, Pamela, Dickson, Ashley ORCID: https://orcid.org/0000-0003-4151-1563, Underwood, Mark A., Andersen, Ditte, Holmes, Elizabeth, Market, Elke, Leung, Hing Y. ORCID: https://orcid.org/0000-0002-3933-3975 and Edwards, Joanne ORCID: https://orcid.org/0000-0002-7192-6906 (2020) Androgen receptor phosphorylation at serine 81 and serine 213 in castrate-resistant prostate cancer. Prostate Cancer and Prostatic Diseases, 23(4), pp. 596-606. (doi: 10.1038/s41391-020-0235-1) (PMID:32358577)

Roseweir, A. K. et al. (2018) Predictive biomarkers for endocrine therapy: retrospective study in Tamoxifen and Exemestane Adjuvant Multinational (TEAM) trial. Journal of the National Cancer Institute, 110(6), pp. 616-627. (doi: 10.1093/jnci/djx255) (PMID:29917140)

Campbell, K. J. et al. (2018) MCL-1 is a prognostic indicator and drug target in breast cancer. Cell Death and Disease, 9, 19. (doi: 10.1038/s41419-017-0035-2) (PMID:29339815) (PMCID:PMC5833338)

Cheng, Kelvin K.W., Dickson, Ashley ORCID: https://orcid.org/0000-0003-4151-1563, Gujam, Fadia J.A., McMillan, Donald C. ORCID: https://orcid.org/0000-0003-4260-5334 and Edwards, Joanne ORCID: https://orcid.org/0000-0002-7192-6906 (2017) The relationship between oestrogen receptor-alpha phosphorylation and the tumour microenvironment in patients with primary operable ductal breast cancer. Histopathology, 70(5), pp. 782-797. (doi: 10.1111/his.13134) (PMID:27891654)